• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Celator Pharmaceuticals - Articles and news items

Jazz Pharmaceuticals to acquire Celator for $1.5 billion

Industry news / 31 May 2016 / Victoria White, Digital Content Producer

The transaction advances Jazz Pharmaceuticals’ growth strategy and adds Celator’s investigational therapy Vyxeous to the company’s portfolio…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +